ImmunitoAI
AI-powered platform for efficient Antibody Drug Design

description
immunitoAI is a biotech startup that aims to make targeted therapy using antibodies a norm. It is developing an AI-powered platform for antibody discovery and screening. The platform screens and ranks the best antibody candidates for a given target/antigen. With this technology, the discovery process can be made 2x more efficient while improving the success rate.
founders
Aridni Shah
Trisha Chatterjee
founded
2020
year of investment
Sep 2021




